If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSENS.L Share News (SENS)

  • There is currently no data for SENS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: Cake Box trading strong; Sensyne falls further

Tue, 19th Apr 2022 11:06

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday.

----------

AIM - WINNERS

----------

Cake Box Holdings PLC, up 11% at 214.00 pence, 12-month range 135.00p-428.00p. The fresh cream cakes retailer said trading across second half ended March 31 was strong and, as a result, expects annual revenue to be up 50%, with adjusted pretax profit in line with market forecasts. "There continues to be a high level of interest in Cake Box's differentiated franchise proposition, with both strong demand for new stores from existing franchisees and a pipeline of new franchisee applicants representing 53 holding deposits held at the period end," it says.

----------

Empyrean Energy PLC, up 9.6% at 11.18p, 12-month range 4.90p-13.00p. Says LH 17-2-1 well at the Jade prospect offshore China drilled 12-1/4" section to 2,150 metres measured depth and results have validated the pre-drill interpretation of seismic data including the presence of gas clouds over the Jade as well as Topaz prospects. "Based on the results thus far, Empyrean has upgraded its internal geological chance of success over the Jade prospect from 41% to 65% and Topaz prospect from 35% to 47%," it says.

----------

AIM - LOSERS

----------

Sensyne Health PLC, down 32% at 1.24p, 12-month range 1.00p-178.00p. Decides to end formal sale process in light of amended financing agreement and will seek approval to delist from AIM. The amendment provides access to up to GBP20 million in additional capital. "Without access to the additional capital provided by the noteholders pursuant to the amended and restated note purchase agreement, the company is unlikely to be able to continue to trade and would very likely become insolvent and be placed into administration," Sensyne warns. Stock down 98% in year-to-date.

----------

Serabi Gold PLC, down 14% at 50.88p, 12-month range 46.00p-80.00p. The Brazil-focused gold miner says production has taken a hit during the first quarter, consequently lowering its full-year production guidance. Gold production in the first quarter at Palito was 7,062 ounces, down 13% year-on-year from 8,087 ounces. Serabi lowers production guidance for 2022 to 30,000 ounces, down from a previous range of between 36,000 and 39,000 ounces.

----------

By Lucy Heming; lucyheming@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
2 Nov 2020 09:27

Sensyne Health app to be used in Covid-19 study

(Sharecast News) - Clinical artificial intelligence (AI) company Sensyne Health announced on Monday that its 'CVm-Health+' app is to be used by the University of Oxford in its 'FACTS' clinical study evaluating the feasibility and acceptability of new point-of-care tests for regular asymptomatic Covid-19 testing in the community.

Read more
28 Oct 2020 15:33

Sensyne Health Partners With Microsoft To Develop AI Technology

Sensyne Health Partners With Microsoft To Develop AI Technology

Read more
26 Oct 2020 17:43

IN BRIEF: Sensyne Partners With Milton Keynes University Hospital

IN BRIEF: Sensyne Partners With Milton Keynes University Hospital

Read more
23 Oct 2020 16:37

IN BRIEF: Sensyne Health Partners Up With Bristol Myers Squibb

IN BRIEF: Sensyne Health Partners Up With Bristol Myers Squibb

Read more
23 Oct 2020 16:04

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more
23 Oct 2020 11:44

Sensyne Health signs research collaboration deal with Bristol Myers Squibb

(Sharecast News) - Clinical artificial intelligence (AI) company Sensyne Health has signed a research collaboration agreement with Bristol Myers Squibb, it announced on Friday.

Read more
1 Oct 2020 17:49

IN BRIEF: Sensyne Signs Data Sharing Deal With NHS Greater Glasgow

IN BRIEF: Sensyne Signs Data Sharing Deal With NHS Greater Glasgow

Read more
30 Sep 2020 21:37

IN BRIEF: Sensyne Health To Provide Software For Covid Treatment Trial

IN BRIEF: Sensyne Health To Provide Software For Covid Treatment Trial

Read more
30 Sep 2020 21:13

UK EARNINGS SUMMARY: Gama Aviation Interim Loss Widens As Revenue Down

UK EARNINGS SUMMARY: Gama Aviation Interim Loss Widens As Revenue Down

Read more
29 Sep 2020 12:45

Acacia Research buys 11.8% stake in Sensyne Health

(Sharecast News) - US-based Acacia Research has acquired LF Equity Income Fund's 11.8% stake in AIM-listed artificial intelligence specialist Sensyne Health.

Read more
10 Sep 2020 19:21

IN BRIEF: Sensyne Health Names Macdonnell As New Operating Chief

IN BRIEF: Sensyne Health Names Macdonnell As New Operating Chief

Read more
10 Sep 2020 10:09

Sensyne Health signs up Michael Macdonnell as new COO

(Sharecast News) - Clinical artificial intelligence (AI) company Sensyne Health has appointed Michael Macdonnell to its senior management team, it announced on Thursday, as its chief operating officer.

Read more
3 Sep 2020 21:22

IN BRIEF: Sensyne Health Launches Sense Engine In UK

IN BRIEF: Sensyne Health Launches Sense Engine In UK

Read more
19 Aug 2020 10:16

Sensyne Health Develops New Diabetes Software Application DBm-Health

Sensyne Health Develops New Diabetes Software Application DBm-Health

Read more
10 Aug 2020 10:45

IN BRIEF: Sensyne Settles Tribunal Claim With Former Finance Chief

IN BRIEF: Sensyne Settles Tribunal Claim With Former Finance Chief

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.